Drugs.com
For patients, caregivers, and healthcare professionals requiring verified medication data, interaction checks, and pill identification.
Drugs.com Medication Guide
Snapshot
Who is Drugs.com?
Providing peer-reviewed medication information and identification tools to help patients and healthcare professionals manage drug safety.
Target audience
Portfolio
Free 2Last updated
Drugs.com Medication Guide
v3.3.0
1mo ago
Publisher DNA
What defines Drugs.com?
Publisher DNA
Primary focus
Medical reference and drug identification utilities
Scale
indie
Target audience
Patients, caregivers, and healthcare professionals requiring verified medication data, interaction checks, and pill identification.
Signature Patterns
- •Focus on peer-reviewed clinical data and pharmacist-verified information
- •Monetization via tiered subscriptions, ranging from monthly ad-removal to high-cost weekly utility access
- •Integration of specialized utility tools like AI image recognition and interaction checkers
- •Frequent update cadence to maintain database accuracy and app performance
Portfolio momentum
Maintained an active development cycle with 9 updates across both apps in the last 6 months, including a major release within the last 8 days.
Portfolio
What does Drugs.com ship?
Apps
3 apps analysed
Look up drug information, identify pills and manage your medications.
High-intent pill identifier utility
- Comprehensive medication interaction checking provides life-saving insights for patients managing multiple prescriptions and supplements
- Aggressive price increases for ad-free access frustrate long-term users who previously paid lower annual rates
Look up drug information, identify pills and manage your medications.
Highly-rated visual Pill Identifier tool
- Medication Management & Information
- Monetization & Pricing
- Medical professionals find the pill identification database useful for verifying medication accuracy during clinical shifts
- Incomplete pill database fails to identify common medications, leading users to label the app as useless
Single-market publisher, every app ships only to United States.
Based on 2 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States2 / 2
Core markets (2/2 apps)
User Sentiment
How do users feel about their apps?
2
Positive apps
0
Neutral / mixed
1
Negative apps
55/100
Avg sentiment score
Unlock the app dragging this portfolio down.
Access the full report for freeRivals
Who does Drugs.com compete with?
The rivals identified
Same space(17)
Cute Pill targets the medication-adherence segment of the Drugs.com audience with a focus on simplicity.
gesund.de serves the pharmacy-fulfillment segment of the Drugs.com audience by connecting users to local German pharmacies.
GoodRx addresses the financial-utility segment of the Drugs.com audience by providing prescription pricing and discount coupons.
mediteo targets the medication-adherence segment of the Drugs.com audience with a focus on privacy-first tracking.
Pillo competes for the medication-adherence segment of the Drugs.com user base by prioritizing persistent alarm mechanics.
TakeYourPills serves the same medication-tracking audience as Drugs.com but focuses on a simplified, all-in-one organizer interface.
apodiscounter targets the pharmacy-fulfillment segment of the Drugs.com audience by offering direct online medication purchasing.
CVS Health captures the pharmacy-fulfillment segment of the Drugs.com audience through physical-digital integration.
Lilly Health™ serves the medication-adherence segment of the Drugs.com audience specifically for Eli Lilly patients.
Healthera targets the pharmacy-fulfillment segment of the Drugs.com audience by integrating with the NHS.
Blood Sugar - Diabetic Checker serves the chronic-condition management segment of the Drugs.com audience.
Liki24 targets the pharmacy-fulfillment segment of the Drugs.com audience by acting as a European health marketplace.
mySugr targets the same medical-management audience by shifting from general drug info to specific diabetes-centric data logging.
MyTherapy serves the same patient base as Drugs.com but focuses on long-term adherence tracking rather than drug information reference.
Prescription en ligne functions as a closed-loop digital portal for ART patients, replacing manual identification with clinic-integrated schedules.
Publix Pharmacy targets the same pharmacy-utility segment as Drugs.com by digitizing the prescription-refill workflow.
WebMD competes directly with Drugs.com by offering a similar medical-reference utility to drive ad-supported traffic.
The Analyst's Read
The bottom line on Drugs.com
Bottom line
Drugs.com is a high-authority medical publisher successfully translating a massive web presence into a specialized mobile portfolio. While their core reference app maintains exceptional user sentiment, the aggressive pricing strategy on utility-focused tools represents a significant pivot toward high-ARPU monetization.
Frequently asked questions
How many apps does Drugs.com publish?
What kind of apps does Drugs.com make?
What is Drugs.com's top app?
In how many countries are Drugs.com's apps available?
What fed this analysis
- Apps analyzed:
- 2
- With full intel:
- 2
- With overview:
- 2
- Website scraped:
- yes
- Social presence:
- yes
